0
EMPOWER NIH Act of 2021
12/31/2022, 4:58 AM
Summary of Bill HR 4211
Specifically, the EMPOWER NIH Act of 2021 proposes a significant increase in funding for the NIH over the next five years. This funding would be used to support a wide range of research initiatives, including studies on diseases such as cancer, Alzheimer's, and diabetes, as well as research into new treatments and cures for various medical conditions.
In addition to increasing funding for the NIH, the bill also includes provisions to streamline the research process and improve collaboration between different research institutions. This would help to ensure that research findings are shared more effectively and that progress is made more quickly in the field of biomedical science. Overall, the EMPOWER NIH Act of 2021 is aimed at strengthening the NIH and supporting important research initiatives that have the potential to improve public health and save lives. It is currently being debated in Congress, and its passage would represent a significant investment in the future of biomedical research in the United States.
Congressional Summary of HR 4211
Enabling More Penetrating Oversight When Examining Research for NIH Act of 2021 or the EMPOWER NIH Act of 2021
This bill requires annual, unannounced, in-person inspections of all nonfederal entities that receive funding, including through subawards, from the National Institutes of Health (NIH) to assess whether the funded research is consistent with the research proposal and otherwise meets record-keeping requirements and NIH standards.
The inspections are required even when an entity is located in a foreign country with a government that interferes with the inspection; entities that fail an inspection must return the full amount of NIH funding and lose eligibility for future NIH funding for at least five years.
The bill is effective on October 1, 2023, and applies to NIH funding awarded both before and after that date.
